Sylvie Demirdjian

506 total citations
10 papers, 394 citations indexed

About

Sylvie Demirdjian is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Occupational Therapy. According to data from OpenAlex, Sylvie Demirdjian has authored 10 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pediatrics, Perinatology and Child Health, 3 papers in Pharmacology and 2 papers in Occupational Therapy. Recurrent topics in Sylvie Demirdjian's work include Childhood Cancer Survivors' Quality of Life (2 papers), Safe Handling of Antineoplastic Drugs (2 papers) and Pharmacy and Medical Practices (2 papers). Sylvie Demirdjian is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (2 papers), Safe Handling of Antineoplastic Drugs (2 papers) and Pharmacy and Medical Practices (2 papers). Sylvie Demirdjian collaborates with scholars based in France. Sylvie Demirdjian's co-authors include M. Bonnay, Jean‐Pierre Pignon, S. Antoun, A. El Otmany, J.F. Ouellet, Michel Ducreux, L. Drouard-Troalen, D. Élias, Valérie Furlan and Olivier Bourdon and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Sylvie Demirdjian

10 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvie Demirdjian France 6 265 177 145 63 38 10 394
J. Belliveau United States 7 209 0.8× 76 0.4× 77 0.5× 109 1.7× 22 0.6× 10 389
V K Kapoor India 13 442 1.7× 98 0.6× 9 0.1× 89 1.4× 24 0.6× 31 544
Kaya Sarıbeyoğlu Türkiye 11 251 0.9× 56 0.3× 13 0.1× 55 0.9× 39 1.0× 36 378
Panagiotis Taflampas Greece 7 243 0.9× 82 0.5× 86 0.6× 112 1.8× 4 0.1× 10 303
Guowei Kim Singapore 12 297 1.1× 43 0.2× 26 0.2× 68 1.1× 32 0.8× 39 401
S. Bruin Netherlands 8 240 0.9× 64 0.4× 41 0.3× 60 1.0× 14 0.4× 11 327
Craig J. Railton Canada 7 210 0.8× 108 0.6× 13 0.1× 77 1.2× 3 0.1× 10 451
Karolin Thiel Germany 10 111 0.4× 28 0.2× 2 0.0× 29 0.5× 38 1.0× 41 242
Diana L. Ersfeld United States 8 107 0.4× 6 0.0× 10 0.1× 42 0.7× 35 0.9× 11 461
C Dietrich Germany 6 85 0.3× 16 0.1× 3 0.0× 118 1.9× 68 1.8× 11 289

Countries citing papers authored by Sylvie Demirdjian

Since Specialization
Citations

This map shows the geographic impact of Sylvie Demirdjian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Demirdjian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Demirdjian more than expected).

Fields of papers citing papers by Sylvie Demirdjian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Demirdjian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Demirdjian. The network helps show where Sylvie Demirdjian may publish in the future.

Co-authorship network of co-authors of Sylvie Demirdjian

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Demirdjian. A scholar is included among the top collaborators of Sylvie Demirdjian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Demirdjian. Sylvie Demirdjian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Lemare, François, et al.. (2018). High-dose thiotepa-related neurotoxicity and the role of tramadol in children. BMC Cancer. 18(1). 177–177. 6 indexed citations
2.
Oudot, Caroline, Agnès Laplanche, Daniel Orbach, et al.. (2011). PCA analgesia for children with chemotherapy-related mucositis: a double-blind randomized comparison of morphine and pethidine. Bulletin du Cancer. 98(2). E11–E18. 5 indexed citations
3.
Bourget, Philippe, et al.. (2003). Contribution of high-performance thin-layer chromatography to a pharmaceutical quality assurance programme in a hospital chemotherapy manufacturing unit. European Journal of Pharmaceutics and Biopharmaceutics. 56(3). 445–451. 19 indexed citations
4.
Élias, D., M. Bonnay, S. Antoun, et al.. (2002). Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Annals of Oncology. 13(2). 267–272. 281 indexed citations
5.
6.
Demirdjian, Sylvie, et al.. (2001). Traçabilité pharmaceutique intégrée au dossier patient. Développement d'une application informatique hospitalière. Pathologie Biologie. 49(8). 624–633. 1 indexed citations
7.
Paci, Angélo, et al.. (2001). Functional spectrum of an HPTLC analysis station in a hospital pharmacy quality assurance program. European Journal of Cancer. 37. S64–S64. 1 indexed citations
8.
Bourget, Philippe, et al.. (2001). Place et spectre fonctionnel de l'HPTLC dans un programme d'assurance qualité pharmaceutique hospitalier. Pathologie Biologie. 49(1). 86–95. 8 indexed citations
9.
Demirdjian, Sylvie, et al.. (2001). Application of High-Performance, Thin-Layer Chromatography to Quality Control of Antimetabolite Analogue Infusion Bags. Journal of AOAC International. 84(4). 1296–1300. 5 indexed citations
10.
Furlan, Valérie, et al.. (1999). Glucuronidation of Drugs by Hepatic Microsomes Derived from Healthy and Cirrhotic Human Livers. Journal of Pharmacology and Experimental Therapeutics. 289(2). 1169–1175. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026